002581 Shandong Sinobioway Biomedicine
- 10.14
- +0.07+0.70%
Shandong Sinobioway Biomedicine News
Unnamed Pharmaceuticals: Announcement on Sale of Assets
Unnamed Pharmaceuticals: Announcement on Proposed Sale of Assets or Proposed Foreign Investment
Unnamed Pharmaceuticals: Announcement on the completion of cancellation and delisting of “17 Unnamed Bonds”
Unnamed Pharmaceutical: Announcement on the results of the resale implementation of “17 Unnamed Bonds”
Unnamed Pharmaceuticals: Report on Provisional Fiduciary Management of Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceutical: Announcement on the results of the resale of “17 Unnamed Bonds” corporate bonds
Unnamed Pharmaceuticals: 2020 Interest Payment Announcement for Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceuticals: Report on Provisional Fiduciary Management of Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceuticals: Third announcement on the non-adjustment of the coupon interest rate of “17 Unnamed Bonds” and the implementation measures for resale by bond holders
Unnamed Pharmaceuticals: Second announcement on the non-adjustment of the coupon interest rate of “17 Unnamed Bonds” and the implementation measures for investor resale
Unnamed Pharmaceuticals: First announcement on the non-adjustment of the coupon interest rate of “17 Unnamed Bonds” and the implementation measures for resale by bond holders
Unnamed Pharmaceuticals: Report on Provisional Fiduciary Management of Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceuticals: 2020 Corporate Bonds Tracking Rating Report
Unnamed Pharmaceuticals: Announcement on matters relating to the adjustment of trading mechanisms during the bond listing period
Unnamed Pharmaceuticals: 2017 Fiduciary Management Report on Public Issuance of Corporate Bonds to Qualified Investors (2019)
Unnamed Pharmaceuticals: Report on Provisional Fiduciary Management of Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceuticals: United Credit Rating Co., Ltd.'s Concern Notice Concerned About the Company and Related Parties Being Publicly Denounced
Unnamed Pharmaceuticals: Report on Provisional Fiduciary Management of Public Issuance of Corporate Bonds to Qualified Investors in 2017
Unnamed Pharmaceuticals: Announcement on the “17 Unnamed Bonds” bond repurchase results
Unnamed Pharmaceuticals: Announcement on the “17 Unnamed Bonds” Bond Repurchase Report
Analysis
Price Target
No Data
No Data